MISSION
Science
that becomes medicine
VISION
PrimeCell team is working 15 years to discover technologies
to treat unmedical needs of civilisation.
STRATEGY
PrimeCell is the bio-med company focusing on discovering and clinical testing of biological drugs and medicinal technologies, which are changing genes and cells parameters to support regeneration of human tissues and organs.
We are proud to our results
in regenerative medicine
Patients/year
SQM OF OUR LABS
RESEARCH PROJECTS
CORE EMPLOYEES
RESEARCH PLATFORM
NEWS
Zentiva získala od společnosti Primecell licenci k biologickým náplastem na chronické rány AMNIODERM
Společnost Zentiva získala od spin-off společnosti BioHealing ze skupiny Primecell licenci k bionáplastem AMNIODERM®, které bude marketovat na českém a evropském trhu. „Jsme rádi, že se tak významný výrobce léčiv, jakým[…]
Read more
Protected: Science Café Ostrava: Inovativní přístupy v léčbě nádorových onemocnění
There is no excerpt because this is a protected post.
Read more
GEN: Remescor, one of the options for COVID-19
18. 5. 2020 – Genetic Engineering & Biotechnology News (GEN) has ranked Remescor (Primecell drug development) into the group of candidates for COVID-19 treatment. More: https://www.genengnews.com/covid-19-candidates/primecell/
Read moreCo-operative transfer research
PrimeCell leads co-operative transfer research with prestigious Universities, Science institutions and technology companies around the world.
